Jonathan R. Goodman - Jun 1, 2023 Form 4 Insider Report for POINT Biopharma Global Inc. (PNT)

Role
Director
Signature
/s/ William L. Demers, by Power of Attorney for Jonathan R. Goodman
Stock symbol
PNT
Transactions as of
Jun 1, 2023
Transactions value $
$0
Form type
4
Date filed
6/5/2023, 05:36 PM
Previous filing
Nov 21, 2022
Next filing
Dec 27, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PNT Stock Option (Right to Buy) Award $0 +44.7K $0.00 44.7K Jun 1, 2023 Common Stock 44.7K $9.12 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option will vest 100% on the first anniversary of the grant date.